{"entity":{"type":"insider","cik":"0001713712","url":"/insider/0001713712","json_url":"/insider/0001713712.json","name":"Flynn Daniel Lee","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":18,"n_filings":13,"first":"2019-01-15","last":"2023-06-21","span_basis":"filed_date"},"name_variants":[{"name":"Flynn Daniel Lee","source":"filing","n_filings":13,"first_seen":"2019-01-15","last_seen":"2023-06-21"}],"transactions":[{"id":8439417,"accession":"0001209191-23-038753","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-038753","line_url":"/filing/0001209191-23-038753#line-1","is_derivative":false,"issuer_cik":"0001654151","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001654151","owner_cik":"0001713712","owner_name":"Flynn Daniel Lee","owner_display_name":"Flynn Daniel Lee","owner_url":"/insider/0001713712","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1655.0,"shares_display":"1,655","price_per_share":14.4018,"price_display":"14.40","price_state":"stated","total_value":23834.979,"total_display":"23,834.98","total_whole":"23,835","shares_owned_after":57158.0,"shares_owned_after_display":"57,158","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-16","filed_date":"2023-06-21","scope":"insider"},{"id":7809873,"accession":"0001209191-23-010488","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-010488","line_url":"/filing/0001209191-23-010488#line-2","is_derivative":false,"issuer_cik":"0001654151","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001654151","owner_cik":"0001713712","owner_name":"Flynn Daniel Lee","owner_display_name":"Flynn Daniel Lee","owner_url":"/insider/0001713712","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1370.0,"shares_display":"1,370","price_per_share":15.099,"price_display":"15.10","price_state":"stated","total_value":20685.63,"total_display":"20,685.63","total_whole":"20,686","shares_owned_after":58813.0,"shares_owned_after_display":"58,813","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-16","filed_date":"2023-02-17","scope":"insider"},{"id":8573001,"accession":"0001209191-23-004001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-004001","line_url":"/filing/0001209191-23-004001#line-1","is_derivative":false,"issuer_cik":"0001654151","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001654151","owner_cik":"0001713712","owner_name":"Flynn Daniel Lee","owner_display_name":"Flynn Daniel Lee","owner_url":"/insider/0001713712","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2403.0,"shares_display":"2,403","price_per_share":21.2413,"price_display":"21.24","price_state":"stated","total_value":51042.8439,"total_display":"51,042.84","total_whole":"51,043","shares_owned_after":43695.0,"shares_owned_after_display":"43,695","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-17","filed_date":"2023-01-19","scope":"insider"},{"id":6956164,"accession":"0001209191-22-038425","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-038425","line_url":"/filing/0001209191-22-038425#line-1","is_derivative":false,"issuer_cik":"0001654151","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001654151","owner_cik":"0001713712","owner_name":"Flynn Daniel Lee","owner_display_name":"Flynn Daniel Lee","owner_url":"/insider/0001713712","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1768.0,"shares_display":"1,768","price_per_share":10.75,"price_display":"10.75","price_state":"stated","total_value":19006.0,"total_display":"19,006.00","total_whole":"19,006","shares_owned_after":46098.0,"shares_owned_after_display":"46,098","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-16","filed_date":"2022-06-21","scope":"insider"},{"id":6693453,"accession":"0001209191-22-011360","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-011360","line_url":"/filing/0001209191-22-011360#line-1","is_derivative":false,"issuer_cik":"0001654151","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001654151","owner_cik":"0001713712","owner_name":"Flynn Daniel Lee","owner_display_name":"Flynn Daniel Lee","owner_url":"/insider/0001713712","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1366.0,"shares_display":"1,366","price_per_share":9.05,"price_display":"9.05","price_state":"stated","total_value":12362.3,"total_display":"12,362.30","total_whole":"12,362","shares_owned_after":47866.0,"shares_owned_after_display":"47,866","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-16","filed_date":"2022-02-18","scope":"insider"},{"id":4925120,"accession":"0001209191-21-012115","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-012115","line_url":"/filing/0001209191-21-012115#line-2","is_derivative":false,"issuer_cik":"0001654151","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001654151","owner_cik":"0001713712","owner_name":"Flynn Daniel Lee","owner_display_name":"Flynn Daniel Lee","owner_url":"/insider/0001713712","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":508.0,"shares_display":"508","price_per_share":48.87,"price_display":"48.87","price_state":"stated","total_value":24825.96,"total_display":"24,825.96","total_whole":"24,826","shares_owned_after":6532.0,"shares_owned_after_display":"6,532","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-16","filed_date":"2021-02-18","scope":"insider"},{"id":8455519,"accession":"0001209191-19-060447","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-060447","line_url":"/filing/0001209191-19-060447#line-1","is_derivative":false,"issuer_cik":"0001654151","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001654151","owner_cik":"0001713712","owner_name":"Flynn Daniel Lee","owner_display_name":"Flynn Daniel Lee","owner_url":"/insider/0001713712","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31029.0,"shares_display":"31,029","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":1861740.0,"total_display":"1,861,740.00","total_whole":"1,861,740","shares_owned_after":35750.0,"shares_owned_after_display":"35,750","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-12","filed_date":"2019-12-13","scope":"insider"},{"id":7842892,"accession":"0001209191-19-060018","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-19-060018","line_url":"/filing/0001209191-19-060018","is_derivative":false,"issuer_cik":"0001654151","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001654151","owner_cik":"0001713712","owner_name":"Flynn Daniel Lee","owner_display_name":"Flynn Daniel Lee","owner_url":"/insider/0001713712","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":122752.0,"shares_display":"122,752","price_per_share":55.0,"price_display":"55.00","price_state":"stated","total_value":6751360.0,"total_display":"6,751,360.00","total_whole":"6,751,360","shares_owned_after":24500.0,"shares_owned_after_display":"24,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-10","filed_date":"2019-12-11","scope":"insider","n_lines":2},{"id":7842881,"accession":"0001209191-19-060018","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-060018","line_url":"/filing/0001209191-19-060018#line-2","is_derivative":false,"issuer_cik":"0001654151","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001654151","owner_cik":"0001713712","owner_name":"Flynn Daniel Lee","owner_display_name":"Flynn Daniel Lee","owner_url":"/insider/0001713712","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30175.0,"shares_display":"30,175","price_per_share":55.0,"price_display":"55.00","price_state":"stated","total_value":1659625.0,"total_display":"1,659,625.00","total_whole":"1,659,625","shares_owned_after":24500.0,"shares_owned_after_display":"24,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-09","filed_date":"2019-12-11","scope":"insider"},{"id":8168236,"accession":"0001209191-19-056408","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-056408","line_url":"/filing/0001209191-19-056408#line-4","is_derivative":false,"issuer_cik":"0001654151","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001654151","owner_cik":"0001713712","owner_name":"Flynn Daniel Lee","owner_display_name":"Flynn Daniel Lee","owner_url":"/insider/0001713712","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":143185.0,"shares_display":"143,185","price_per_share":48.0139,"price_display":"48.01","price_state":"stated","total_value":6874870.2715,"total_display":"6,874,870.27","total_whole":"6,874,870","shares_owned_after":24500.0,"shares_owned_after_display":"24,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-11","filed_date":"2019-11-13","scope":"insider"},{"id":8168219,"accession":"0001209191-19-056408","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-056408","line_url":"/filing/0001209191-19-056408#line-2","is_derivative":false,"issuer_cik":"0001654151","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001654151","owner_cik":"0001713712","owner_name":"Flynn Daniel Lee","owner_display_name":"Flynn Daniel Lee","owner_url":"/insider/0001713712","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9742.0,"shares_display":"9,742","price_per_share":48.0,"price_display":"48.00","price_state":"stated","total_value":467616.0,"total_display":"467,616.00","total_whole":"467,616","shares_owned_after":24500.0,"shares_owned_after_display":"24,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-08","filed_date":"2019-11-13","scope":"insider"},{"id":8010746,"accession":"0001209191-19-054497","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-054497","line_url":"/filing/0001209191-19-054497#line-2","is_derivative":false,"issuer_cik":"0001654151","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001654151","owner_cik":"0001713712","owner_name":"Flynn Daniel Lee","owner_display_name":"Flynn Daniel Lee","owner_url":"/insider/0001713712","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29820.0,"shares_display":"29,820","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":1192800.0,"total_display":"1,192,800.00","total_whole":"1,192,800","shares_owned_after":24500.0,"shares_owned_after_display":"24,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-28","filed_date":"2019-10-30","scope":"insider"},{"id":7789864,"accession":"0001209191-19-045818","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-045818","line_url":"/filing/0001209191-19-045818","is_derivative":false,"issuer_cik":"0001654151","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001654151","owner_cik":"0001713712","owner_name":"Flynn Daniel Lee","owner_display_name":"Flynn Daniel Lee","owner_url":"/insider/0001713712","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":148107.0,"shares_display":"148,107","price_per_share":40.921462194224446,"price_display":"40.92","price_state":"stated","total_value":6060755.0012,"total_display":"6,060,755.00","total_whole":"6,060,755","shares_owned_after":54212.0,"shares_owned_after_display":"54,212","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-13","filed_date":"2019-08-13","scope":"insider","n_lines":3},{"id":8022950,"accession":"0001209191-19-004547","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-004547","line_url":"/filing/0001209191-19-004547#line-4","is_derivative":false,"issuer_cik":"0001654151","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001654151","owner_cik":"0001713712","owner_name":"Flynn Daniel Lee","owner_display_name":"Flynn Daniel Lee","owner_url":"/insider/0001713712","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":152629.0,"shares_display":"152,629","price_per_share":26.0,"price_display":"26.00","price_state":"stated","total_value":3968354.0,"total_display":"3,968,354.00","total_whole":"3,968,354","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-16","filed_date":"2019-01-18","scope":"insider"},{"id":8723774,"accession":"0001209191-19-003735","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-003735","line_url":"/filing/0001209191-19-003735#line-2","is_derivative":false,"issuer_cik":"0001654151","issuer_name":"Deciphera Pharmaceuticals, Inc.","issuer_ticker":"DCPH","issuer_name_source":null,"issuer_url":"/issuer/0001654151","owner_cik":"0001713712","owner_name":"Flynn Daniel Lee","owner_display_name":"Flynn Daniel Lee","owner_url":"/insider/0001713712","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":26.0,"price_display":"26.00","price_state":"stated","total_value":7800.0,"total_display":"7,800.00","total_whole":"7,800","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-11","filed_date":"2019-01-15","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":18,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":18,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":18},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001654151","name":"Deciphera Pharmaceuticals, Inc.","url":"/issuer/0001654151","role":"Officer (Chief Scientific Officer)","n_filings":13,"first_seen":"2019-01-15","last_seen":"2023-06-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001713712","retrieved_at":"2026-08-27T01:19:52+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}